A

Angiocrine Bioscience, Inc.

32 employees

Angiocrine Bioscience develops a cellular platform to amplify stem and progenitor cells in both human and mouse models.

Basic info

biotechnology research

Biotechnology

Therapeutics

hematopoietic stem cell gene therapy.

Proprietary genetically engineered cellular E-CEL™ Technology Platform

Health Diagnostics

with potential applications in cellular immunotherapy for hematologic cancers

Health Care

cellular regenerative medicine

2012